Dihydrogenated Ergot Alkaloids in the Treatment of Essential Hypertension
- 1 February 1952
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 5 (2) , 285-286
- https://doi.org/10.1161/01.cir.5.2.285
Abstract
The effect of the oral and intravenous administration of the dihydrogenated ergot alkaloids on 25 cases of essential hypertension in the age group of 25 to 56 is reported with reference to (1) incidence of hypotensive effect, (2) degree of hypotensive effect, (3) duration of the hypotensive effect.Keywords
This publication has 1 reference indexed in Scilit: